cilomilast has been researched along with saquinavir in 2 studies
Studies (cilomilast) | Trials (cilomilast) | Recent Studies (post-2010) (cilomilast) | Studies (saquinavir) | Trials (saquinavir) | Recent Studies (post-2010) (saquinavir) |
---|---|---|---|---|---|
162 | 13 | 42 | 1,454 | 256 | 219 |
Protein | Taxonomy | cilomilast (IC50) | saquinavir (IC50) |
---|---|---|---|
Voltage-dependent L-type calcium channel subunit alpha-1F | Homo sapiens (human) | 1.9 | |
Bile salt export pump | Homo sapiens (human) | 3.9 | |
Gag-Pol polyprotein | Human immunodeficiency virus type 1 (BRU ISOLATE) | 0.016 | |
Gag-Pol polyprotein | Human immunodeficiency virus type 2 (ISOLATE ROD) | 0.0084 | |
Gag polyprotein | HIV-1 M:B_MN | 0.0131 | |
ATP-dependent translocase ABCB1 | Homo sapiens (human) | 4.05 | |
Cytochrome P450 3A4 | Homo sapiens (human) | 1.5 | |
Gag-Pol polyprotein | Human immunodeficiency virus type 1 (NEW YORK-5 ISOLATE) | 0.0066 | |
5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 4.273 | |
Substance-K receptor | Homo sapiens (human) | 6.214 | |
Thromboxane-A synthase | Homo sapiens (human) | 2.182 | |
5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 4.273 | |
Mu-type opioid receptor | Homo sapiens (human) | 9.625 | |
Kappa-type opioid receptor | Homo sapiens (human) | 6.951 | |
Exoribonuclease H | Human immunodeficiency virus 2 | 0.0005 | |
Voltage-dependent L-type calcium channel subunit alpha-1D | Homo sapiens (human) | 1.9 | |
Voltage-dependent L-type calcium channel subunit alpha-1S | Homo sapiens (human) | 1.9 | |
Voltage-dependent L-type calcium channel subunit alpha-1C | Homo sapiens (human) | 1.9 | |
Genome polyprotein | Human rhinovirus sp. | 0.0005 | |
Solute carrier family 22 member 1 | Rattus norvegicus (Norway rat) | 8.26 | |
Protease | Human immunodeficiency virus 1 | 0.0217 | |
Protease | Human immunodeficiency virus 1 | 0.0004 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
2 other study(ies) available for cilomilast and saquinavir
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |